UEFA Appeals Body’s decision on anti-doping rule violation


On 28 November 2019, following the 2019/20 UEFA Europa League group stage match (the “Match”) between Malmö FF and FC Dynamo Kyiv, Mr Artem Biesiedin (the “Player”) underwent an in-competition doping control test undertaken by UEFA. The analysis of the Player’s sample by a WADA-accredited laboratory revealed the presence of Fonturacetam which is a stimulant that is prohibited in-competition pursuant to S6 (a) of the 2019 WADA Prohibited List. Following an initial review, disciplinary proceedings were opened by UEFA against the Player on 7 January 2020.

On 31 January 2020, the chairman of the UEFA Control, Ethics & Disciplinary Body decided to refer these proceedings to the UEFA Appeals Body for a decision pursuant Article 29(3) of the UEFA Disciplinary Regulations.

The UEFA Appeals Body decided at its meeting on 24 February 2020, following a hearing, to suspend the FC Dynamo Kyiv player Mr. Artem Biesiedin for one (1) year, starting from the date in which the Control, Ethics and Disciplinary Body decided to provisionally suspend Mr. Artem Biesiedin (i.e. 19 December 2019) and ending on 19 December 2020, for committing an anti-doping rule violation.

No appeal was lodged against the UEFA Appeals Body decision of 24 February 2020 to the Court of Arbitration for Sport and therefore the decision is final.

Leave a comment

Please login to leave a comment.


Legal Advisors

Upcoming Events

There are no up-coming events

Copyright © LawInSport Limited 2010 - 2020. These pages contain general information only. Nothing in these pages constitutes legal advice. You should consult a suitably qualified lawyer on any specific legal problem or matter. The information provided here was accurate as of the day it was posted; however, the law may have changed since that date. This information is not intended to be, and should not be used as, a substitute for taking legal advice in any specific situation. LawInSport is not responsible for any actions taken or not taken on the basis of this information. Please refer to the full terms and conditions on our website.